PROVIDER PROFILE · NPI 1023371515

Wanxing Chai-HoM.D.

Hematology-OncologyLos Angeles, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,116

Unique beneficiaries

—

Total services

12,528

Distinct HCPCS

Medicare payment

$560K

Peer benchmark

Total Medicare services vs. 957 Hematology-Oncology providers in CA — top quintile (cohort median 4,173).

PRESCRIBING · PART D · 2024

Total Rx claims

816

Beneficiaries

—

Total drug cost

$2.0M

Distinct drugs

Brand share

34.9%

Top prescribed drugs

Acyclovir83 claims

Levofloxacin63 claims

Ruxolitinib Phosphate56 claims

Levothyroxine Sodium53 claims

Posaconazole44 claims

QUALITY · MIPS · 2024

Final MIPS score

87.5

Quality

79.4

Cost

73.7

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.53%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$413

Payment records

By payment type

Food and Beverage$413

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 050112

Hospital

CCN 050262

Hospital

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history